Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELAS GRANDE PHARMACIE RIQUET : revenue, balance sheet and financial ratios

SELAS GRANDE PHARMACIE RIQUET is a French company founded 12 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in PARIS (75019), this company of category PME shows in 2022 a net income positive of 211 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELAS GRANDE PHARMACIE RIQUET (SIREN 799116561)
Indicator 2022 2020 2019 2018 2017
Revenue N/C N/C N/C N/C N/C
Net income 210 894 € 123 576 € 160 161 € 178 328 € 157 267 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2022, SELAS GRANDE PHARMACIE RIQUET generates positive net income of 211 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2022: 157 k€ -> 211 k€.

Net income (2022) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

210 894 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 786%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 9%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2022) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

786.281%

Financial autonomy (2022) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

9.445%

Asset age ratio (2022) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

13.3%

Solvency indicators evolution
SELAS GRANDE PHARMACIE RIQUET

Sector positioning

Debt ratio
786.28 2022
2019
2020
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Average +5 pts over 3 years

In 2022, the debt ratio of SELAS GRANDE PHARMACIE RI... (786.28) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
9.45% 2022
2019
2020
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Average -7 pts over 3 years

In 2022, the financial autonomy of SELAS GRANDE PHARMACIE RI... (9.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 211.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2022) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

211.723

Liquidity indicators evolution
SELAS GRANDE PHARMACIE RIQUET

Sector positioning

Liquidity ratio
211.72 2022
2019
2020
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Good +21 pts over 3 years

In 2022, the liquidity ratio of SELAS GRANDE PHARMACIE RI... (211.72) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Positioning of SELAS GRANDE PHARMACIE RIQUET in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 215 transactions of similar company sales in 2022, the value of SELAS GRANDE PHARMACIE RIQUET is estimated at 2 481 486 € (range 1 668 051€ - 3 721 768€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2022
215 transactions
1668k€ 2481k€ 3721k€
2 481 486 € Range: 1 668 051€ - 3 721 768€
NAF 5 année 2022

Valuation method used

Net Income Multiple
210 894 € × 11.8x = 2 481 486 €
Range: 1 668 052€ - 3 721 768€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELAS GRANDE PHARMACIE RIQUET with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELAS GRANDE PHARMACIE RIQUET

What is the revenue of SELAS GRANDE PHARMACIE RIQUET ?

The revenue of SELAS GRANDE PHARMACIE RIQUET is not publicly disclosed (confidential accounts filed with INPI).

Is SELAS GRANDE PHARMACIE RIQUET profitable?

Yes, SELAS GRANDE PHARMACIE RIQUET generated a net profit of 211 k€ in 2022.

Where is the headquarters of SELAS GRANDE PHARMACIE RIQUET ?

The headquarters of SELAS GRANDE PHARMACIE RIQUET is located in PARIS (75019), in the department Paris.

Where to find the tax return of SELAS GRANDE PHARMACIE RIQUET ?

The tax return of SELAS GRANDE PHARMACIE RIQUET is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELAS GRANDE PHARMACIE RIQUET operate?

SELAS GRANDE PHARMACIE RIQUET operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.